SCHEMBL1476860

SCHEMBL1476860

CCC(C)(O)C(Cl)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4654114 0.75
Water SCHEMBL3997763 0.73
SCHEMBL11340652 0.73
SCHEMBL22300 0.71
SCHEMBL1490142 0.71
SCHEMBL13354747 0.71
SCHEMBL13312865 0.71
SCHEMBL11329665 0.71
SCHEMBL30132067 0.69
SCHEMBL30358284 0.69 TSHR (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7915423-B2 Dissolving pantoprazole and sodium hydroxide in 2-propanol, tetrahydrofuran, acetonitrile, methanol, ethanol, water, mixtures of sec-butanol and dichloromethane, or ethyl acetate diluent, crystallizing pantoprazole sodium sesquihydrate, isolating TEVA PHARMACEUTICAL INDUSTRIES, LTD. (IL) 2011-03-29 US disclosed
US-7507829-B2 Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates TEVA PHARMACEUTICALS INDUSTRIES, LTD (IL) 2009-03-24 US disclosed
US-20080132707-A1 Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates TEVA PHARMACEUTICALS USA, INC. FOR BARBADOS. 2008-06-05 US disclosed
US-20040177804-A1 Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates TEVA PHARMACEUTICAL INDUSTRIES, LTD. (IL) 2004-09-16 US disclosed
EP-0495265-B1 Acid-labile linker molecules AKZO NOBEL NV (NL) 1994-08-03 EP disclosed
US-5306809-A Cancer immune therapy AKZO N.V. (NL) 1994-04-26 US disclosed
EP-0495265-A1 Acid-labile linker molecules Akzo Nobel N.V. (NL) 1992-07-22 EP disclosed